· 2 min read
The UK and the EU agreed on a new “Windsor Framework” for Northern Ireland (NI) that, when implemented, will change the status of medicines in the Northern Ireland.
Under the current NI Protocol, medicines in Northern Ireland are regulated by the EU, as NI is still in the EU single market to avoid a hard border on the island of Ireland.
The Windsor Framework changes this arrangement as follows:
The MHRA, HRA and Northern Ireland Department of Health put forward proposals and consulted on them from January 17 to March 14, 2023.
The organizations referenced above proposed to amend the current legislation to:
Pharmaceutical legislation and regulatory authority guidance are continually changing. These changes and their interpretation can have significant implications for companies. Many changes require detailed planning to implement, and failure to do so can result in serious compliance problems. This pharmaceutical regulatory training provides you with 12 months of updates of changes to legislation and guidance that have the potential to impact the manufacture and distribution of medicinal/drug products. A full update for the past year and a summary of what is new each quarter will be provided in February, May, September and late November. Your subscription will start with the next available update.
Complete your details below to receive the newsletter.